1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Industries

  • All
    • Autoimmune Disease

Top Countries

  • All
    • Australasia

Publication dates

2 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 211 pages

The targeted subindications are mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

  • Autoimmune Disease
  • Leukemia
  • Lymphoma
  • Therapy
  • Australasia

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) – Pipeline Review, H2 2017

  • $ 3500
  • August 2017
  • 74 pages

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) – Pipeline Review, H2 2017 Summary Sphingosine ...

  • Autoimmune Disease
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Australasia


View report >

Diabetes Statistics and Autoimmune Disease Statistics

  • January 2006
  • 12 pages

CHAPTER ## NEW PATIENTS COMMENCING TREATMENT IN 2006 STEPHEN MCDONALD SEAN CHANG LEONIE EXCELL Figure ##. ## Figure ##. ## INTAKE OF NEW PATIENTS There were ## new patients who commenced treatment for end-stage renal failure in Australia in 2006, a rate of ## per million population per year.

  • Autoimmune Disease
  • Chronic Disease
  • Diabetes
  • Australasia
  • Australia

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on